Skip to content
← Back to this collection

PUBLICATIONS · 29438093

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2018 Jun
First author
Odogwu L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Odogwu L
      type
      Author
    2. name
      Mathieu L
      type
      Author
    3. name
      Blumenthal G
      type
      Author
    4. name
      Larkins E
      type
      Author
    5. name
      Goldberg KB
      type
      Author
    6. name
      Griffin N
      type
      Author
    7. name
      Bijwaard K
      type
      Author
    8. name
      Lee EY
      type
      Author
    9. name
      Philip R
      type
      Author
    10. name
      Jiang X
      type
      Author
    11. name
      Rodriguez L
      type
      Author
    12. name
      McKee AE
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Odogwu L
      type
      Author
    2. name
      Mathieu L
      type
      Author
    3. name
      Blumenthal G
      type
      Author
    4. name
      Larkins E
      type
      Author
    5. name
      Goldberg KB
      type
      Author
    6. name
      Griffin N
      type
      Author
    7. name
      Bijwaard K
      type
      Author
    8. name
      Lee EY
      type
      Author
    9. name
      Philip R
      type
      Author
    10. name
      Jiang X
      type
      Author
    11. name
      Rodriguez L
      type
      Author
    12. name
      McKee AE
      type
      Author
    bibliography ids
    1. nci-bib-8c27b2ef81e9eb42048aaca9
    book metadata
    content sha256
    106f14e1ab3c870c31c5ae9a4d34b3009201a88e5bd2fc08e5c17747f6961549
    document type
    citation
    dois
    1. 10.1634/theoncologist.2017-0642
    electronic publication date
    display
    2018 Feb 7
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29438093
    immutable id
    pubmed:29438093@106f14e1ab3c870c31c5ae9a4d34b3009201a88e5bd2fc08e5c17747f6961549
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    6
    name
    The oncologist
    nlm unique id
    9607837
    pages
    740-745
    volume
    23
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29438093
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      f0ae471a36670a2047f23fce0017080996197264653bf5751ecfc7df75c2c616
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 Jun
      precision
      month
      year
      2018
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29438093/
      title
      FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations.

      Preserved source evidence · Not medical advice